A strong order book from one or two major buyers feels like a win. It often is, right up until that buyer delays a payment, renegotiates terms, or runs into trouble of their own. Buyer concentration, having a large share of your revenue tied to a small number of customers, is one of the most common and most underplanned risks in SME financing. It doesn't show up as a warning sign in your growth numbers. It shows up as a crisis the day one relationship falters.
Why concentration is riskier than it feels
A business generating steady revenue from two or three large buyers can look financially strong on paper: solid order volumes, predictable cash flow, low customer acquisition cost. The risk is structural, not visible in a P&L statement until something goes wrong. For a mid-sized business with meaningful export receivables, it's common for the top five buyers to account for close to half of total exposure. When accounts stretch beyond 85 to 90 days outstanding, a single large buyer's insolvency can be enough to wipe out a year's profit or breach a banking covenant, not because the business was poorly run, but because too much of it depended on one relationship holding up.
A frequently cited rule of thumb: if one or two buyers make up more than roughly 40% of your revenue, that concentration has crossed from manageable into genuinely dangerous territory.
Why this matters even more for financing than for sales
Concentration risk doesn't just threaten your cash flow if a buyer defaults. It directly shapes what financing you can actually get. Lenders routinely cap how much of a facility can be drawn against a single buyer, specifically because they don't want to be as exposed to one counterparty as you are. If your revenue is concentrated and your financing facility has a per-buyer cap, you may discover that a large share of your receivables simply can't be financed at all under that facility, right when you need the capital most.
This is worth knowing before you're mid-negotiation on a facility, not after a term sheet arrives with a concentration limit that quietly excludes most of your actual business.
Building concentration risk into the plan, not just reacting to it
Know your actual number. Calculate what percentage of your revenue comes from your top buyer, and your top three to five. Many businesses have never run this calculation explicitly and are surprised by what it shows.
Diversify deliberately, not opportunistically. Winning a second or third major buyer relationship is a financing decision as much as a sales one. A business actively working to reduce its largest buyer's share of revenue is building resilience into its own balance sheet, not just growing.
Use trade credit insurance where exposure is genuinely large. Trade credit insurance protects specific receivables against buyer insolvency or protracted default, and is particularly relevant for businesses where one or two customers dominate revenue. In India, this is available both through the government-backed ECGC and through private insurers, typically priced as a small percentage of insured turnover. Coverage on your largest, riskiest exposures specifically, rather than blanket coverage on everything, is usually the more cost-effective starting point.
Ask about concentration limits before you sign, not after. When evaluating a financing facility, ask directly how much can be drawn against any single buyer, and check that number against your actual buyer mix. A facility that looks generous in total size can turn out to cover only a fraction of your real receivables if your business is concentrated and the facility's per-buyer cap is tight.
Keep a liquidity buffer sized to your actual concentration, not a generic rule. A business with three evenly split buyers needs a different cushion than one with a single buyer representing 60% of revenue. Size your buffer to the real risk, not a rounded industry average.
Monitor buyer health continuously, not just at onboarding. Buyer creditworthiness isn't static. A buyer that looked solid a year ago can weaken well before it shows up as a missed payment, and catching that shift early gives you time to adjust exposure rather than absorb a surprise default.
How CapitalXB approaches buyer concentration
As an RBI-licensed NBFC-Factor, CapitalXB evaluates financing against the strength of individual transactions and buyer relationships, which means concentration is something we look at directly with an exporter rather than applying a blanket limit that ignores the reality of their buyer base. For businesses genuinely concentrated in one or two relationships, that conversation, what's financeable, what needs additional protection like credit insurance, and where diversification should be a priority, is one worth having early, not after a facility has already been structured around an incomplete picture.
The bottom line
Buyer concentration isn't a red flag to be ashamed of, most growing SMEs go through a phase where a handful of buyers drive most of their revenue. The mistake isn't having concentration. It's not planning your financing, your insurance, and your diversification strategy around it while things are going well, and finding out the hard way what it costs when they don't.